{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T18:50:00Z","timestamp":1782499800033,"version":"3.54.5"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016800","name":"Natural Science Foundation of Xuzhou Municipality","doi-asserted-by":"publisher","award":["KC22267"],"award-info":[{"award-number":["KC22267"]}],"id":[{"id":"10.13039\/100016800","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016800","name":"Natural Science Foundation of Xuzhou Municipality","doi-asserted-by":"publisher","award":["KC23131"],"award-info":[{"award-number":["KC23131"]}],"id":[{"id":"10.13039\/100016800","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204708"],"award-info":[{"award-number":["82204708"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jchromb.2025.124871","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T07:48:22Z","timestamp":1764056902000},"page":"124871","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["UPLC-MS\/MS-based targeted analysis of human serum revealed that aberrant arachidonic acid metabolism may contribute to the pathogenesis of type 2 diabetes mellitus"],"prefix":"10.1016","volume":"1269","author":[{"given":"Peng","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-wan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-jie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dao-quan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2025.124871_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.jchromb.2025.124871_bb0010","doi-asserted-by":"crossref","DOI":"10.1002\/cph4.70003","article-title":"Type 2 diabetes mellitus: a comprehensive review of pathophysiology, comorbidities, and emerging therapies","volume":"15","author":"Singh","year":"2025","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.jchromb.2025.124871_bb0015","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41392-023-01399-3","article-title":"Small molecule metabolites: discovery of biomarkers and therapeutic targets","volume":"8","author":"Qiu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jchromb.2025.124871_bb0020","doi-asserted-by":"crossref","first-page":"836","DOI":"10.2337\/dc22-1435","article-title":"Plasma lipidomic n-6 polyunsaturated fatty acids and type 2 diabetes risk in the EPIC-potsdam prospective cohort study","volume":"46","author":"Prada","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jchromb.2025.124871_bb0025","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41392-020-00443-w","article-title":"Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jchromb.2025.124871_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2020.106482","article-title":"Regulation of arachidonic acid oxidation and metabolism by lipid electrophiles","volume":"152","author":"Trostchansky","year":"2021","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.jchromb.2025.124871_bb0035","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s00125-018-4558-6","article-title":"Differential expression of Lp-PLA2 in obesity and type 2 diabetes and the influence of lipids","volume":"61","author":"Jackisch","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.jchromb.2025.124871_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.plefa.2020.102157","article-title":"Evaluation of cyclooxygenase oxylipins as potential biomarker for obesity-associated adipose tissue inflammation and type 2 diabetes using targeted multiple reaction monitoring mass spectrometry","volume":"160","author":"Tans","year":"2020","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.jchromb.2025.124871_bb0045","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3892\/ijmm.2021.4947","article-title":"Role of 2-series prostaglandins in the pathogenesis of type 2 diabetes mellitus and non-alcoholic fatty liver disease (review)","volume":"47","author":"Wang","year":"2021","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.jchromb.2025.124871_bb0050","doi-asserted-by":"crossref","first-page":"E792","DOI":"10.1152\/ajpendo.00383.2014","article-title":"Thromboxane synthase deficiency improves insulin action and attenuates adipose tissue fibrosis","volume":"308","author":"Lei","year":"2015","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.jchromb.2025.124871_bb0055","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1111\/j.1742-4658.2010.07565.x","article-title":"Pronounced adipogenesis and increased insulin sensitivity caused by overproduction of prostaglandin D2 in vivo","volume":"277","author":"Fujitani","year":"2010","journal-title":"FEBS J."},{"key":"10.1016\/j.jchromb.2025.124871_bb0060","first-page":"389","article-title":"Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities","volume":"16","author":"B\u00e4ck","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.jchromb.2025.124871_bb0065","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.metabol.2017.01.034","article-title":"Obesity is positively associated with arachidonic acid-derived 5- and 11-hydroxyeicosatetraenoic acid (HETE)","volume":"70","author":"Pickens","year":"2017","journal-title":"Metabolism"},{"key":"10.1016\/j.jchromb.2025.124871_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112518","article-title":"Structure-based design, semi-synthesis and anti-inflammatory activity of tocotrienolic amides as 5-lipoxygenase inhibitors","volume":"202","author":"Dinh","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jchromb.2025.124871_bb0075","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.plipres.2018.11.001","article-title":"Emerging role of 12\/15-lipoxygenase (ALOX15) in human pathologies","volume":"73","author":"Singh","year":"2019","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.jchromb.2025.124871_bb0080","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.3945\/an.116.012245","article-title":"The role of cytochrome p450 epoxygenases, soluble epoxide hydrolase, and epoxyeicosatrienoic acids in metabolic diseases","volume":"7","author":"Xu","year":"2016","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.jchromb.2025.124871_bb0085","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.prostaglandins.2016.05.004","article-title":"EETs\/sEH in diabetes and obesity-induced cardiovascular diseases","volume":"125","author":"Huang","year":"2016","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.jchromb.2025.124871_bb0090","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/1753-0407.12358","article-title":"Soluble epoxide hydrolase: a potential target for metabolic diseases","volume":"8","author":"He","year":"2016","journal-title":"J. Diabetes"},{"key":"10.1016\/j.jchromb.2025.124871_bb0095","doi-asserted-by":"crossref","first-page":"1501305","DOI":"10.3389\/fendo.2025.1501305","article-title":"Clinical metabolomics in type 2 diabetes mellitus: from pathogenesis to biomarkers","volume":"16","author":"Liu","year":"2025","journal-title":"Front. Endocrinol."},{"issue":"4","key":"10.1016\/j.jchromb.2025.124871_bb0100","doi-asserted-by":"crossref","first-page":"548","DOI":"10.33314\/jnhrc.v17i4.1042","article-title":"The declaration of Helsinki on medical research involving human subjects: a review of seventh revision","volume":"17","author":"Shrestha","year":"2020","journal-title":"J Nepal Health Res Counc"},{"issue":"Suppl. 1","key":"10.1016\/j.jchromb.2025.124871_bb0105","first-page":"S20","article-title":"American Diabetes Association professional practice committee. 2. Diagnosis and classification of diabetes: standards of Care in Diabetes-2024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jchromb.2025.124871_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2024.342433","article-title":"Addressing the untargeted lipidomics challenge in urine samples: comparative study of extraction methods by UHPLC-ESI-QTOF-MS","volume":"1299","author":"Fernandez Requena","year":"2024","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jchromb.2025.124871_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2025.127610","article-title":"Comprehensive untargeted polar metabolite analysis using solvent switching liquid chromatography tandem mass spectrometry","volume":"287","author":"Violi","year":"2025","journal-title":"Talanta"},{"key":"10.1016\/j.jchromb.2025.124871_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2021.122688","article-title":"Cross platform solutions to improve the zebrafish polar metabolome coverage using LC-QTOF MS: optimization of separation mechanisms, solvent additives, and resuspension solvents","volume":"234","author":"Xu","year":"2021","journal-title":"Talanta"},{"key":"10.1016\/j.jchromb.2025.124871_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115304","article-title":"Simultaneous measurement of kynurenine metabolites and explorative metabolomics using liquid chromatography-mass spectrometry: a novel accurate method applied to serum and plasma samples from a large healthy cohort","volume":"227","author":"Eggertsen","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2025.124871_bb0130","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jare.2018.01.002","article-title":"Arachidonic acid in health and disease with focus on hypertension and diabetes mellitus: a review","volume":"11","author":"Das","year":"2018","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.jchromb.2025.124871_bb0135","doi-asserted-by":"crossref","first-page":"2749173","DOI":"10.1155\/2019\/2749173","article-title":"Emerging roles of 5-lipoxygenase phosphorylation in inflammation and cell death","volume":"2019","author":"Sun","year":"2019","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.jchromb.2025.124871_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104189","article-title":"Plasma epoxyeicosatrienoic acids and diabetes-related cardiovascular disease: the cardiovascular health study","volume":"83","author":"Lemaitre","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jchromb.2025.124871_bb0145","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.bbrc.2020.01.085","article-title":"Soluble epoxide hydrolase inhibitor protects against blood-brain barrier dysfunction in a mouse model of type 2 diabetes via the AMPK\/HO-1 pathway","volume":"524","author":"Wu","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jchromb.2025.124871_bb0150","first-page":"698","article-title":"Plasma and urinary concentrations of arachidonic acid-derived eicosanoids are associated with diabetic kidney disease","volume":"20","author":"Mota-Zamorano","year":"2021","journal-title":"EXCLI J."},{"key":"10.1016\/j.jchromb.2025.124871_bb0155","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1109\/TPAMI.2022.3145392","article-title":"Deep ROC analysis and AUC as balanced average accuracy, for improved classifier selection, audit and explanation","volume":"45","author":"Carrington","year":"2023","journal-title":"IEEE Trans. Pattern Anal. Mach. Intell."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023225004258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023225004258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T18:14:09Z","timestamp":1782497649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023225004258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":31,"alternative-id":["S1570023225004258"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2025.124871","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"UPLC-MS\/MS-based targeted analysis of human serum revealed that aberrant arachidonic acid metabolism may contribute to the pathogenesis of type 2 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2025.124871","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124871"}}